Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention.

ABSTRACT:

Background

Clopidogrel is an antiplatelet therapy that is widely used in pre and post percutaneous (PCI) coronary intervention procedures to prevent platelet aggregation and stent restenosis. However, there is a wide inter-individual variation in clopidogrel response and some patients showed resistance against the activity of Clopidogrel. Kinase insert domain receptor (KDR) gene is responsible for the transcription of vascular endothelial growth factor receptor 2 (VEGFR2) that plays a major role in the cardiovascular diseases (CVDs) and platelet aggregation. The aim of this study was to find out the association of KDR rs1870377 genotype with clopidogrel resistance (CR) in CVD patients, of Iraqi Arabic origin, hospitalized for elective PCI.

Materials and methods

SUBMITTER: Al Awaida W 

PROVIDER: S-EPMC7900686 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature